Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Marc Edwards Insider Profile
4 Followers
Marc Edwards, President & Chief Executive Officer at Kane Biotech, holds 5.89M shares in Kane Biotech (Ticker: TSE:KNE). Most recently, Marc Edwards Bought C$125,000 shares of Kane Biotech on Sep 20, 2023 for an estimated value of 10.00K.
Marc Edwards Kane Biotech (KNE)President & Chief Executive Officer
Kane Biotech (KNE)
President & Chief Executive Officer
Ranked #8,610 out of 98,909 Corporate Insiders
Profitable Transactions
7 out of 9 Profitable Transactions
Average Return
+21.20%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & Chief Executive Officer
Roles that Marc Edwards holds in companies
Most Profitable Insider Trade
The most profitable trade made by Marc Edwards
Marc Edwards's Trading History
List of latest transactions for each holding click on a transaction to see Marc Edwards's performance on stock
You May Also Like
Marc Edwards insider profile FAQ
What is the percentage of profitable transactions made by Marc Edwards?
The percentage of profitable transactions made by Marc Edwards is 78%.
What is the average return per transaction made by Marc Edwards?
The average return per transaction made by Marc Edwards is 21.20%.
What stocks does Marc Edwards hold?
Marc Edwards holds: TSE:KNE stocks.
What was Marc Edwards’s latest transaction?
Marc Edwards latest transaction was an Informative Buy of C$10.00K.
What was Marc Edwards's most profitable transaction?
Marc Edwards’s most profitable transaction was an Informative Buy of TSE:KNE stock on September 20, 2023. The return on the trade was 86.60%.
What is Marc Edwards's role in Kane Biotech?
Marc Edwards's role in Kane Biotech is President & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.